Skip to main content
Glama

iplookup

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. v1 supports \"company\"."New value: +"Entity type: \"company\" or \"drug\"."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "drug"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker, CIK, or company name (e.g., \"AAPL\", \"0000320193\", \"Apple\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."
  3. Added

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark the tool read-only, idempotent, open-world, and non-destructive. The description goes well beyond that by disclosing internal multi-endpoint cascading, graceful degradation when GLEIF/OpenFIGI are unavailable, explicit `unresolved` reporting, source-labelled identifiers, and `figi_candidates` for ambiguous matches. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description contains almost no waste and front-loads examples and the key 'Use FIRST' routing instruction. However, the main body is one very dense paragraph with deeply nested parentheticals, which makes it harder to scan than an ideal structured description with clear separation per entity type.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a complex two-parameter tool with no output schema, the description is remarkably complete: it covers both entity branches, identifier families returned, source labelling, unresolved identifiers, ambiguous security matches, and degraded enrichment behavior. An agent has enough information to invoke the tool correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description adds substantial meaning beyond the schema: it explains that `value` accepts ticker, CIK, ISIN, or company name; distinguishes drug brand vs generic input; and warns not to append security-class words when resolving bond issuers. This materially improves correct invocation.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description uses a specific verb ('resolve') and resource ('user-spoken NAME to canonical/official identifiers'), with trigger-phrase examples that show exactly what category of question it answers. It also names supported entity types and frames itself as the tool that supplies IDs other tools require, which separates it from profile/compare siblings.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says 'Use FIRST whenever you have a name but need an ID' and gives example phrasings plus acceptable input forms, which is clear usage guidance. It does not name alternative tools or state when not to use it, so it lacks a full when/when-not exclusion set.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All iplookup toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation2/5

Several tool groups have unclear boundaries: ask_pipeworx and ask_pipeworx_beta are explicitly identical right now, polymarket_edges/arbitrage/bet_research overlap heavily, and scan_competitor_ai_presence merely wraps ai_visibility_check. An agent would frequently have to guess which of several overlapping tools to call.

Naming Consistency3/5

Most tools use lowercase snake_case, but the set mixes verb-first names (resolve_entity, validate_claim) with noun/service-first compounds (polymarket_edges, pipeworx_trending, ai_visibility_check) and inconsistent suffix semantics (ask_pipeworx_beta vs ask_pipeworx_grounded). The pattern is readable but not predictable.

Tool Count2/5

33 tools is far too many for a server named iplookup; only 2 of 33 relate to IP geolocation. The rest form a sprawling data/prediction-market/memory platform that would be better split into multiple focused servers.

Completeness4/5

Within the actual described scope (a Pipeworx data platform), coverage is strong: routed lookups, grounded verification, deep research, entity identity/profile/comparison, claim validation, discovery, subscriptions, memory, feedback, trending, and a full prediction-market arbitrage suite. Minor gaps exist (no direct pack-listing tool, no update for memory values), but there are no critical dead ends.

Resources